Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2

Lancet

Volumn 351, Issue 9097, 1998, Pages 186-187

  Brown, Susan ^a   Bantar, Carlos ^b   Young, Hilary Kay ^b   Amyes, Sebastian G B ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 METHYL 1,2,3 TRIAZOL 4 YLMETHYLENE)PENEM 3 CARBOXYLIC ACID; BACTERIAL ENZYME; CARBAPENEM; CLAVULANIC ACID; EDETIC ACID; IMIPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL;

EID: 0032539467     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78210-6     Document Type: Article

References (5)

1. 1 Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. Characterisation of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 1994; 32: 2677-81.
2. 2 Paton H, Miles RS, Hood J, Amyes SGB. ARI-1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antiomicrob Agents 1993; 2: 81-88.
3. 3 Brown S, Bantar C, Young H-K, Amyes SGB. An outbreak of imipenem-resistance in Acinetobacter strains from Buenos Aires, Argentina. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1996 (abstr C122, p 56). Washington, DC: American Society for Microbiology.
4. 4 British Society for Antimicrobial Chemotherapy Working Party. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 (suppl D): 1-50.
5. 5 Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40; 135-36.